Der Kaninchen Polyklonal Anti-MAGEA4-Antikörper wurde für WB, ELISA, IHC (p) und IF validiert. Er ist geeignet, MAGEA4 in Proben von Human, Ratte und Maus zu detektieren.
Produktnummer ABIN6992141
Kurzübersicht für MAGEA4 Antikörper (N-Term) (ABIN6992141)
MAGEA4 antibody is human specific. At least four isoforms of MAGEA4 are known to exist.
Aufreinigung
MAGEA4 antibody is affinity chromatography purified via peptide column.
Immunogen
MAGEA4 antibody was raised against a 16 amino acid peptide near the amino terminus of human MAGEA4. The immunogen is located within the first 50 amino acids of MAGEA4.
MAGEA4
Reaktivität: Human
WB
Wirt: Maus
Polyclonal
unconjugated
Applikationshinweise
MAGEA4 antibody can be used for detection of MAGEA4 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples, Immunocytochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
MAGEA4 antibody is supplied in PBS containing 0.02 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C,4 °C
Informationen zur Lagerung
MAGEA4 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
MAGEA4
(Melanoma Antigen Family A, 4 (MAGEA4))
Andere Bezeichnung
MAGEA4
Hintergrund
MAGEA4 is a member of the melanoma-associated antigen family that consists of a number of antigens recognized by cytotoxic T lymphocytes (1). MAGEA4 may serve as a target for antitumoral vaccination and may play a role in embryonal development and tumor transformation or aspects of tumor progression. It is expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma and have been implicated in some hereditary disorders, such as dyskeratosis congenital (2-4).